Á lódáil...
Cost–utility analysis of 21-gene assay for node-positive early breast cancer
BACKGROUND: For women with lymph node (ln)–positive, estrogen receptor–positive, and her2 (human epidermal growth factor receptor 2)–negative breast cancer (bca), current guidelines recommend treatment with both hormonal therapy and chemotherapy. The 21-gene Recurrence Score (rs) assay might be help...
Na minha lista:
| Foilsithe in: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Multimed Inc.
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821112/ https://ncbi.nlm.nih.gov/pubmed/31708649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4769 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|